Merck KGaA Statistics

Total Valuation

Merck KGaA has a market cap or net worth of GBP 53.17 billion. The enterprise value is 59.60 billion.

Market Cap	53.17B
Enterprise Value	59.60B

Important Dates

The next estimated earnings date is Thursday, March 6, 2025.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	Apr 29, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.16%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	129.20M

Valuation Ratios

The trailing PE ratio is 23.70.

PE Ratio	23.70
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	14.57
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.50, with an EV/FCF ratio of 27.51.

EV / Earnings	26.56
EV / Sales	3.36
EV / EBITDA	13.50
EV / EBIT	19.97
EV / FCF	27.51

Financial Position

The company has a current ratio of 1.33, with a Debt / Equity ratio of 0.40.

Current Ratio	1.33
Quick Ratio	0.80
Debt / Equity	0.40
Debt / EBITDA	2.18
Debt / FCF	4.38
Interest Coverage	14.89

Financial Efficiency

Return on equity (ROE) is 9.54% and return on invested capital (ROIC) is 5.58%.

Return on Equity (ROE)	9.54%
Return on Assets (ROA)	4.41%
Return on Capital (ROIC)	5.58%
Revenue Per Employee	280,206
Profits Per Employee	36,037
Employee Count	62,908
Asset Turnover	0.42
Inventory Turnover	1.84

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.71% in the last 52 weeks. The beta is 0.71, so Merck KGaA's price volatility has been lower than the market average.

Beta (5Y)	0.71
52-Week Price Change	-1.71%
50-Day Moving Average	142.30
200-Day Moving Average	156.06
Relative Strength Index (RSI)	57.17
Average Volume (20 Days)	172,392

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Merck KGaA had revenue of GBP 17.44 billion and earned 2.24 billion in profits. Earnings per share was 5.15.

Revenue	17.44B
Gross Profit	10.26B
Operating Income	2.94B
Pretax Income	2.80B
Net Income	2.24B
EBITDA	4.22B
EBIT	2.94B
Earnings Per Share (EPS)	5.15

Full Income Statement

Balance Sheet

The company has 3.21 billion in cash and 9.48 billion in debt, giving a net cash position of -6.27 billion.

Cash & Cash Equivalents	3.21B
Total Debt	9.48B
Net Cash	-6.27B
Net Cash Per Share	n/a
Equity (Book Value)	23.63B
Book Value Per Share	54.19
Working Capital	2.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 3.67 billion and capital expenditures -1.50 billion, giving a free cash flow of 2.17 billion.

Operating Cash Flow	3.67B
Capital Expenditures	-1.50B
Free Cash Flow	2.17B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 58.80%, with operating and profit margins of 16.83% and 12.86%.

Gross Margin	58.80%
Operating Margin	16.83%
Pretax Margin	16.07%
Profit Margin	12.86%
EBITDA Margin	24.20%
EBIT Margin	16.83%
FCF Margin	12.42%

Dividends & Yields

Merck KGaA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	-3.19%
Years of Dividend Growth	n/a
Payout Ratio	38.24%
Buyback Yield	-0.16%
Shareholder Yield	-0.16%
Earnings Yield	4.22%
FCF Yield	4.07%

Dividend Details

Stock Splits

The last stock split was on June 30, 2014. It was a forward split with a ratio of 2.

Last Split Date	Jun 30, 2014
Split Type	Forward
Split Ratio	2

Scores

Merck KGaA has an Altman Z-Score of 3.23.

Altman Z-Score	3.23
Piotroski F-Score	n/a